Immunovant to Host Graves' Disease Program Update on September 9, 2024

2 weeks ago

NEW YORK, Sept. 05, 2024 ( GLOBE NEWSWIRE ) -- Immunovant, Inc. IMVT, a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases, today announced that it will host an investor webcast on Monday, September 9th at 8:00 a.m.

Ticker	Sentiment	Impact
IMVT	Somewhat Bullish	70 %